Greg Yanik

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report

Carrie L. Kitko, Joseph Pidala, Hélène Schoemans et al. · Transplantation and Cellular Therapy · 2021 · 167 citations · Full text

Life Sciences, Immunology, Early Detection +12

Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy.

Barry L. Shulkin, Raymond J. Hutchinson, Valerie P. Castle et al. · Radiology · 1996 · 161 citations

Medicine, Nuclear Medicine, Radiology +14

Extramedullary relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes

Andrew C. Harris, Carrie L. Kitko, Daniel R. Couriel et al. · Haematologica · 2012 · 117 citations · Full text

Medicine, Hematology, Oncology +17

Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma

Steven G. DuBois, Yaël P. Mossé, Elizabeth Fox et al. · Clinical Cancer Research · 2018 · 88 citations

Medicine, Oncology, Pharmacology +8

Phase I Study of Vincristine, Irinotecan, and 131I-Metaiodobenzylguanidine for Patients with Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial

Steven G. DuBois, Louis Chesler, Susan Groshen et al. · Clinical Cancer Research · 2012 · 73 citations · Full text

Medicine, Oncology, Pharmacology +16